| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 05/19/1999 | EP0752986B1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists |
| 05/19/1999 | CN1216767A Novel 5-membered ring heterocycles, their prepn. their use and pharmaceutical preparations comprising them |
| 05/18/1999 | US5905088 Skin disorders, rheumatic diseases, respiratory system or cardiovascular disorders and opthalmological disorders |
| 05/18/1999 | US5905084 5-HTIF -agonists effective in treating migraine |
| 05/18/1999 | US5904144 Method for delivering a biologically active molecule to the eye |
| 05/18/1999 | CA2179264C 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists |
| 05/14/1999 | WO1999023105A1 Vegi, an inhibitor of angiogenesis and tumor growth |
| 05/14/1999 | WO1999023076A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors |
| 05/14/1999 | WO1999022713A1 Sustained release ophthalmic compositions containing water soluble medicaments |
| 05/14/1999 | CA2309175A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors |
| 05/14/1999 | CA2302379A1 Sustained release ophthalmic compositions containing water soluble medicaments |
| 05/12/1999 | EP0915086A1 Phenylsulfonamide derivatives |
| 05/12/1999 | EP0914827A1 Ophthalmic drug compositions |
| 05/12/1999 | EP0914459A2 Adenoviral mediated gene transfer in adipocytes and related implants |
| 05/12/1999 | EP0914456A1 Gene expression in monocytes and macrophages |
| 05/12/1999 | EP0914330A1 Novel compounds |
| 05/12/1999 | EP0914168A1 New medicaments containing gelatin cross-linked with oxidized polysaccharides |
| 05/12/1999 | EP0914158A2 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity |
| 05/12/1999 | EP0914102A1 Compositions and methods for treating or preventing diseases of body passageways |
| 05/11/1999 | US5902791 Metalloproteinase inhibitors |
| 05/11/1999 | US5902598 Sustained release drug delivery devices |
| 05/11/1999 | CA2160874C Nasal aromatic releasing compositions |
| 05/06/1999 | WO1999021996A1 Methods and compositions for the diagnosis and treatment of cataracts |
| 05/06/1999 | WO1999021831A1 Tricyclic compounds as cgmp-pde inhibitors |
| 05/06/1999 | WO1999021617A2 Allosteric adenosine receptor modulators |
| 05/06/1999 | WO1999021546A1 N,N-DIETHYLGLYCOLAMIDO ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS |
| 05/06/1999 | WO1999021538A2 Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye |
| 05/06/1999 | WO1999021512A1 Methods and pharmaceutical compositions for the closure of retinal breaks |
| 05/06/1999 | EP0913477A2 LacC gene encoding a tagatose-6-phosphate kinase |
| 05/06/1999 | EP0913476A2 Ornithine carbamoyl transferase sequence and uses thereof |
| 05/06/1999 | EP0913155A2 Pharmaceutical formulation for treating liver disorders |
| 05/06/1999 | EP0912553A1 BENZO[g]QUINOLINE DERIVATIVES |
| 05/06/1999 | EP0912518A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 05/06/1999 | EP0912507A1 Cyclopentan(en)oic acid, 2-alkenyl derivatives as therapeutic agents in the treatment of ocular hypertension |
| 05/06/1999 | EP0912496A1 Inhibition of matrix metalloproteases by acetylene containing compounds |
| 05/06/1999 | EP0912487A1 Substituted oxobutyric acids as matrix metalloprotease inhibitors |
| 05/06/1999 | EP0912183A1 Heterocyclic compounds |
| 05/06/1999 | DE19748763A1 Verwendung von Vasopressin-Antagonisten Use of vasopressin antagonists |
| 05/06/1999 | CA2309135A1 N,n-diethylglycolamido ester prodrugs of indole spla2 inhibitors |
| 05/06/1999 | CA2306379A1 Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye |
| 05/06/1999 | CA2305349A1 Methods and pharmaceutical compositions for the closure of retinal breaks |
| 05/05/1999 | CN1216043A Substd. benzenesulfonamide derivs as prodrugs of COX-2 inhibitors |
| 05/05/1999 | CN1215988A Ophthalmic compound with extended dwell time on eye |
| 05/04/1999 | US5900407 Method of treating dry eye disease with uridine triphosphates and related compounds |
| 05/04/1999 | US5900257 Cosmetic/pharmaceutical compositions comprising lanthanide manganese, tin and/or yttrium salts as substance P antagonists |
| 05/04/1999 | CA2184604C Bicyclic carbamates |
| 05/04/1999 | CA2074641C Method of treating ocular inflammation |
| 04/30/1999 | CA2249056A1 Lacc |
| 04/30/1999 | CA2248996A1 Novel ornithine carbamoyltransferase |
| 04/29/1999 | WO1999020601A1 α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| 04/29/1999 | WO1999020262A1 Remedy for meniere disease |
| 04/29/1999 | WO1999020261A2 Use of antigunal agents for the topial treatment of fungus-induced mucositis |
| 04/29/1999 | WO1999006070A9 Switchable viscoelastic systems containing galactomannan polymers and borate |
| 04/29/1999 | WO1998048027A9 Materials and methods for treatment of retinal diseases |
| 04/29/1999 | DE19747195A1 Compositions for treating diabetic retinopathy |
| 04/29/1999 | CA2307308A1 Medicine for treatment of meniere's disease |
| 04/29/1999 | CA2305798A1 .alpha.-aryl-n-alkylnitrones and pharmaceutical compositions containing the same |
| 04/28/1999 | EP0911410A2 Era polynucleotides and polypeptides from Streptococcus pneumoniae belonging to the GTPase family |
| 04/28/1999 | EP0911409A2 Deformylase |
| 04/28/1999 | EP0911407A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC |
| 04/28/1999 | EP0911406A2 Histidine kinase from Staphylococcus aureus |
| 04/28/1999 | EP0911403A2 MurB gene from Streptococcus pneumoniae |
| 04/28/1999 | EP0911402A2 PyrR homolog from Staphylococcus aureus |
| 04/28/1999 | EP0911333A1 Pyrazolo[4,3-d]pyrimidine derivatives and pharmaceutical compositions containing them |
| 04/28/1999 | EP0910571A2 Novel antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis |
| 04/28/1999 | EP0910566A1 Heterocyclic compounds and their preparation and use |
| 04/28/1999 | EP0910399A1 Stable pharmaceutical composition of bdnf |
| 04/28/1999 | EP0910370A1 Compositions comprising a nitrone compound for use in treating ocular inflammation |
| 04/28/1999 | EP0910358A1 Phenyl derivatives useful as blockers of chloride channels |
| 04/28/1999 | EP0784629B1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/28/1999 | EP0737184B1 Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
| 04/28/1999 | CN1215407A Human antibodies that bind huma TNF 'alpha' |
| 04/28/1999 | CN1215391A 6-phenylpyridyl-2-amine derivatives |
| 04/28/1999 | CN1215338A Pharmaceutical combination containing a compound having angiotensin II and antagonisti activity |
| 04/27/1999 | US5898066 Trophic factors for central nervous system regeneration |
| 04/22/1999 | WO1999019351A1 Novel npy family member |
| 04/22/1999 | WO1999019300A1 Prostaglandin agonists and their use to treat bone disorders |
| 04/22/1999 | WO1999018963A1 Use of flunarizine for the topical treatment of glaucoma |
| 04/22/1999 | WO1999018962A1 Pharmaceutically active compound and methods of use |
| 04/22/1999 | WO1999001136A9 Novel substituted imidazole compounds |
| 04/22/1999 | CA2308009A1 Novel npy family member |
| 04/22/1999 | CA2306276A1 Pharmaceutically active compound and methods of use |
| 04/21/1999 | EP0909820A2 Histidine kinase from Staphylococcus pneumoniae |
| 04/21/1999 | EP0793641B1 Metalloproteinase inhibitors |
| 04/21/1999 | EP0633261B1 Quinoline-3-acetic acid derivative, process for producing the same, and use thereof |
| 04/21/1999 | CN1214624A Improved tissue destruction in cryosurgery by use of thermal hysteresis proteins |
| 04/15/1999 | WO1999018076A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/15/1999 | WO1999018074A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | WO1999017780A1 Dexamethasone gel |
| 04/15/1999 | WO1999017770A1 Indeno[1,2-c]pyrazole derivatives for inhibiting tyrosine kinase activity |
| 04/15/1999 | WO1999017769A1 INDENO[1,2-c]-, NAPHTHO[1,2-c]- AND BENZO[6,7]CYCLOHEPTA[1,2-c]PYRAZOLE DERIVATIVES |
| 04/15/1999 | WO1999009025A3 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor |
| 04/15/1999 | DE19744113A1 Ophthalmological dexamethasone preparation |
| 04/15/1999 | CA2305679A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | CA2304565A1 Indeno[1,2-c]-, naphtho[1,2-c]- and benzo[6,7]cyclohepta[1,2-c]pyrazole derivatives |
| 04/15/1999 | CA2304466A1 Indeno[1,2-c]pyrazole derivatives for inhibiting tyrosine kinase activity |
| 04/15/1999 | CA2303449A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/14/1999 | EP0908519A1 Novel glucosaminidase from Staphylococcus aureus |
| 04/14/1999 | EP0907738A1 Novel compounds |
| 04/14/1999 | EP0907732A2 Polynucleotides encoding secreted proteins |